Loading
Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Latest filing published 24 Feb 2023 for CinCor Pharma, Inc.. Read the official filing
Filing timeline
BuySaleMarc de Garidel
Insider track record
Disclosed buys
1
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
Marc de Garidel: trading record in brief
This profile gathers the share dealings of Marc de Garidel in CinCor Pharma, Inc., where the filings describe the role as chief executive. The record holds 3 filings, for trades running from 11 January 2022 to 24 February 2023.
The open-market record is one-sided, with 1 purchase worth €177k and not one sale. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Other entries cover 1 share grant.
The record was last updated on 24 February 2023 with a transaction in CinCor Pharma, Inc. The last insider purchase was made public on 13 January 2022, 1,739 days ago. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Marc de Garidel
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations3 total
12,500 sharesCommon StockSEC:0001209191-23-012890:0
200,000 sharesCommon StockSEC:0001209191-23-005596:0
12,500 shares@ US$16.00100.0% of flowCommon StockSEC:0001209191-22-003186:0
Canonical exit: 11 Apr 2022 (T+90)
3 of 3 declarations
